Vijay Kumar
Stock Analyst at Evercore ISI
(3.39)
# 2,311
Out of 4,455 analysts
514
Total ratings
47.6%
Success rate
2.7%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Initiated Coverage: Buy | $30 | $22.56 | +32.98% | 1 | Jun 24, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | n/a | $90.78 | - | 33 | Jun 16, 2026 | |
| MDT Medtronic | Maintained: Buy | $106 | $80.98 | +30.90% | 21 | Jun 4, 2026 | |
| GH Guardant Health | Upgraded: Buy | $95 → $160 | $149.22 | +7.22% | 5 | Jun 2, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | $30 | $18.50 | +62.16% | 8 | May 9, 2026 | |
| ENOV Enovis | Maintained: Buy | $35 → $36 | $22.71 | +58.52% | 13 | May 8, 2026 | |
| PEN Penumbra | Maintained: Buy | $345 → $335 | $316.63 | +5.80% | 7 | May 7, 2026 | |
| WAT Waters | Maintained: Buy | $350 | $374.41 | -6.52% | 14 | May 5, 2026 | |
| BDX Becton, Dickinson and Company | Initiated Coverage: Buy | $275 → $180 | $155.92 | +15.44% | 16 | May 4, 2026 | |
| ILMN Illumina | Maintained: Buy | $150 → $155 | $176.55 | -12.21% | 22 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $365 → $355 | $332.71 | +6.70% | 26 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $15.43 | +29.62% | 21 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 → $160 | $118.89 | +34.58% | 4 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.5 → $8 | $10.28 | -22.18% | 17 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $16.32 | -1.96% | 11 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $80 | $65.76 | +21.65% | 13 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $350.85 | - | 3 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $196.19 | +14.68% | 16 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $480 | $404.70 | +18.61% | 43 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $134 → $120 | $94.12 | +27.50% | 24 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $160 → $140 | $136.01 | +2.93% | 17 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $23 → $22 | $22.04 | -0.18% | 19 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 → $80 | $44.23 | +80.87% | 26 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $35 | $25.50 | +37.25% | 17 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,400 → $1,425 | $1,263.75 | +12.76% | 16 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $118 → $108 | $113.02 | -4.44% | 19 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $650 → $575 | $513.03 | +12.08% | 21 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $52 → $56 | $99.84 | -43.91% | 10 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $104 → $120 | $93.10 | +28.89% | 23 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $4.46 | n/a | 9 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $150 | $102.42 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $2.5 | $1.47 | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $264.02 | n/a | 1 | Nov 9, 2022 |
PROCEPT BioRobotics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $22.56
Upside: +32.98%
Edwards Lifesciences
Jun 16, 2026
Maintained: Buy
Price Target: n/a
Current: $90.78
Upside: -
Medtronic
Jun 4, 2026
Maintained: Buy
Price Target: $106
Current: $80.98
Upside: +30.90%
Guardant Health
Jun 2, 2026
Upgraded: Buy
Price Target: $95 → $160
Current: $149.22
Upside: +7.22%
Caris Life Sciences
May 9, 2026
Maintained: Buy
Price Target: $30
Current: $18.50
Upside: +62.16%
Enovis
May 8, 2026
Maintained: Buy
Price Target: $35 → $36
Current: $22.71
Upside: +58.52%
Penumbra
May 7, 2026
Maintained: Buy
Price Target: $345 → $335
Current: $316.63
Upside: +5.80%
Waters
May 5, 2026
Maintained: Buy
Price Target: $350
Current: $374.41
Upside: -6.52%
Becton, Dickinson and Company
May 4, 2026
Initiated Coverage: Buy
Price Target: $275 → $180
Current: $155.92
Upside: +15.44%
Illumina
May 1, 2026
Maintained: Buy
Price Target: $150 → $155
Current: $176.55
Upside: -12.21%
May 1, 2026
Maintained: Buy
Price Target: $365 → $355
Current: $332.71
Upside: +6.70%
May 1, 2026
Maintained: Buy
Price Target: $16 → $20
Current: $15.43
Upside: +29.62%
May 1, 2026
Maintained: Buy
Price Target: $170 → $160
Current: $118.89
Upside: +34.58%
Apr 30, 2026
Maintained: Hold
Price Target: $8.5 → $8
Current: $10.28
Upside: -22.18%
Apr 30, 2026
Maintained: Hold
Price Target: $17 → $16
Current: $16.32
Upside: -1.96%
Apr 30, 2026
Maintained: Buy
Price Target: $85 → $80
Current: $65.76
Upside: +21.65%
Apr 23, 2026
Maintained: Buy
Price Target: n/a
Current: $350.85
Upside: -
Apr 21, 2026
Maintained: Buy
Price Target: $225
Current: $196.19
Upside: +14.68%
Apr 20, 2026
Maintained: Hold
Price Target: $480
Current: $404.70
Upside: +18.61%
Apr 16, 2026
Maintained: Buy
Price Target: $134 → $120
Current: $94.12
Upside: +27.50%
Apr 6, 2026
Rated: Buy
Price Target: $160 → $140
Current: $136.01
Upside: +2.93%
Apr 6, 2026
Rated: Buy
Price Target: $23 → $22
Current: $22.04
Upside: -0.18%
Apr 6, 2026
Rated: Buy
Price Target: $96 → $80
Current: $44.23
Upside: +80.87%
Apr 6, 2026
Rated: Buy
Price Target: $45 → $35
Current: $25.50
Upside: +37.25%
Apr 6, 2026
Rated: Buy
Price Target: $1,400 → $1,425
Current: $1,263.75
Upside: +12.76%
Apr 6, 2026
Rated: Buy
Price Target: $118 → $108
Current: $113.02
Upside: -4.44%
Apr 6, 2026
Maintained: Buy
Price Target: $650 → $575
Current: $513.03
Upside: +12.08%
Apr 6, 2026
Rated: Buy
Price Target: $52 → $56
Current: $99.84
Upside: -43.91%
Jan 5, 2026
Upgraded: Buy
Price Target: $104 → $120
Current: $93.10
Upside: +28.89%
May 19, 2025
Maintained: Hold
Price Target: $3
Current: $4.46
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $160 → $150
Current: $102.42
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $2 → $2.5
Current: $1.47
Upside: n/a
Nov 9, 2022
Maintained: Buy
Price Target: $93
Current: $264.02
Upside: n/a